About this trial
High school and middle school students who want to quit vaping will be randomized to receive the Kick-Nic! app or a control NCI website to determine the efficacy of the app for vaping cessation. Participants will be screened for eligibility, then go through an 8 week treatment period where they will be given access to use the Kick-Nic! app or referred to the NCI Quit Vaping website. This will be followed by 1.5, 3, 4.5 and then 6 month follow up visits. Qualitative interviews with participants and school staff will also be conducted to obtain feedback on the app and best ways to implement/disseminate the app.
Abstinence rates will be assessed biweekly during treatment including at end of treatment (EOT), and then at 1.5, 3, 4.5 and then 6 months follow ups (FU). Biochemical verification (salivary cotinine \< 30 ng.ml) of self-reports of abstinence will be conducted at EOT and 6-month FU.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
high school or middle school aged youth (12-19 years old),
regular current (past month) e-cig users using nicotine-containing e-cigs at least 1 day/week.
want to quit using e-cigarettes.
have a smartphone with data/WIFI plan in order to access and utilize the KickNic! app
Disqualifiers
Those who have non-stable (<2 months) use of anxiolytics, antidepressants, and other psychostimulants or have a history of psychosis or any significant current psychiatric/medical condition that would increase risk will be excluded.
Trial design
Parallel
Treatments tested in this trial
Kick-Nic! mobile phone application
BehavioralThe Kick-Nic! app has seven modules that cover core CBT strategies using skills, graphic illustrations, and interactive components to help adolescents quit using e-cigarettes.
NCI Quit Vaping website
BehavioralThe NCI webpage provides quitting tobacco resources for youth, including for e-cigarettes. The information provided is similar to the CBT skills modeled by the Kick-Nic! app.
Treatment groups
Trial outcomes
Primary outcomes
Timeline Follow Back (self-report) with saliva cotinine (biochemical verification) at 6 month follow up.
Timeline Follow Back (self-report) determining 7-day point prevalence of e-cigarette use confirmed by saliva cotinine \<30ng/mL at 6 month follow up visit.
Secondary outcomes
Timeline Follow Back (self-report) with saliva cotinine (biochemical verification) at End of Treatment (EOT).
Timeline Follow Back (self-report) determining 7-day point prevalence of e-cigarette use confirmed by saliva cotinine \<30ng/mL at EOT visit.
Timeline Follow Back (self-report) at EOT, 3, and 6 month follow up
Timeline Follow Back (self-report) will be used to determine % days e-cigarette free and continuous abstinence of e-cigarette use at EOT, 3 month, and 6 month follow up.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Yale University
Lead sponsor
National Cancer Institute (NCI)
Collaborator